Description

Oligonucleotide synthesis is the chemical process by which nucleotides are specifically linked to form the desired sequenced product. The technique is extremely useful in current laboratory practice because it provides a rapid and inexpensive access to custom-made oligonucleotides of the desired sequence. According to StrategyHelix, the global oligonucleotide synthesis market is expected to increase by US$ 4,683.6 million during 2022-2028, expanding at a CAGR of 9.7% during the forecast period.

The report provides up-to-date market size data for period 2018-2021 and forecast to 2028 covering key market aspects like sales value for oligonucleotide synthesis. The global oligonucleotide synthesis market is segmented on the basis of product, application, end user, and region. Based on product, the global oligonucleotide synthesis market is categorized into oligonucleotide drugs, synthesized oligonucleotides, reagents, equipment, services. The oligonucleotide drugs segment captured the largest share of the market in 2021. On the basis of application, the global oligonucleotide synthesis market has been segmented into diagnostics, therapeutics, research. The research segment held the largest share of the global oligonucleotide synthesis market in 2021 and is anticipated to hold its share during the forecast period. By end user, the global oligonucleotide synthesis market has been segmented into pharmaceutical & biotechnology companies, diagnostic laboratories, academic research institutes. In 2021, the academic research institutes segment made up the largest share of revenue generated by the oligonucleotide synthesis market. Geographically, the global oligonucleotide synthesis market is segmented into North America, Asia Pacific, Europe, Rest of the World (ROW). Among these, North America was accounted for the highest revenue generator in 2021.

The global oligonucleotide synthesis market is highly competitive. The prominent players operating in the global oligonucleotide synthesis market include Agilent Technologies Inc., Biolegio BV, Biolytic Lab Performance Inc., CustomArray Inc., Danaher Corporation, Eurofins Scientific SE, LGC Ltd., Merck KGaA, Microsynth AG, Thermo Fisher Scientific Inc.

The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the oligonucleotide synthesis market to help drive informed decision making for industry executives, policy makers, academic, and analysts.

Report Scope

Product: oligonucleotide drugs, synthesized oligonucleotides, reagents, equipment, services
Application: diagnostics, therapeutics, research
End user: pharmaceutical & biotechnology companies, diagnostic laboratories, academic research institutes
Region: North America, Asia Pacific, Europe, Rest of the World (ROW)
Years considered: this report covers the period 2018 to 2028

Key Benefits for Stakeholders

– Get a comprehensive picture of the global oligonucleotide synthesis market
– Pinpoint growth sectors and trends for investment

Table of Contents

Part 1. Introduction
– Scope of the study
– Study period
– Geographical scope
– Research methodology
Part 2. Oligonucleotide synthesis market overview
Part 3. Market breakdown by product
– Oligonucleotide drugs
– Synthesized oligonucleotides
– Reagents
– Equipment
– Services
Part 4. Market breakdown by application
– Diagnostics
– Therapeutics
– Research
Part 5. Market breakdown by end user
– Pharmaceutical & biotechnology companies
– Diagnostic laboratories
– Academic research institutes
Part 6. Market breakdown by region
– North America
– Asia Pacific
– Europe
– Rest of the World (ROW)
Part 7. Key companies
– Agilent Technologies, Inc.
– Biolegio BV
– Biolytic Lab Performance, Inc.
– CustomArray, Inc.
– Danaher Corporation
– Eurofins Scientific SE
– LGC Ltd.
– Merck KGaA
– Microsynth AG
– Thermo Fisher Scientific Inc.
About StrategyHelix
Disclaimer